Want to know more about Centerstone’s new
program to fight treatment-resistant depression?
Centerstone has begun a new therapy program where we offer Spravato™ – a nasal spray that contains the FDA-approved medication Esketamine – for individuals seeking treatment for severe depression.
WHO IS THIS FOR?
Esketamine is for adults who have been treated for depression but haven’t experienced improvement in their symptoms.
HOW DOES IT WORK?
Spravato™ is administered under the supervision of a medical professional after patients complete a comprehensive screening with a Centerstone physician. Each confidential treatment takes approximately two hours.
HOW MUCH DOES IT COST?
Esketamine costs vary based on a number of factors, including dose required and any prescription assistance from Janssen, but will range from $975 to $1,275 per treatment session. A complete course of Esketamine therapy typically consists of 14 sessions over a 12-week period. Payment is required at time of service.
WHERE IS THIS OFFERED?
Centerstone offers this comprehensive assessment and treatment at our Bradenton, Florida location.
Centerstone is a not-for-profit health care organization dedicated to delivering care that changes people’s lives. We provide mental health and substance abuse treatment, education and support to communities in Florida, Illinois, Indiana, Kentucky and Tennessee and additionally offer individuals with intellectual and developmental disabilities life skills development, employment and housing services. Nationally, we have specialized programs for service members, veterans and their loved ones, and develop employee assistance programs for businesses of all sizes. Our research institute improves behavioral healthcare through research and technology, and our foundation secures philanthropic resources to support our work. For more information, visit Centerstone.org.